Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma

Press/Media

Period7 Dec 2019 → 11 Dec 2019

Media coverage

20

Media coverage